For crews flying survey planes, an advanced medium format system now targets under‑one‑centimeter detail. With this release aimed at national survey programs and linear work, Phase One brings the ...
Vigil Neuroscience reported positive Phase 1 trial results for VG-3927 and plans a Phase 2 trial in Q3 2025. Vigil Neuroscience, Inc. announced promising outcomes from a Phase 1 clinical trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results